BlackRock Japan’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

BlackRock Japan’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Hold	7,184	–	–	﹤0.01%	1224
2016 Q3	$11K	Hold	7,184	–	–	﹤0.01%	1196
2016 Q2	$10K	Buy	+7,184	New	+$33.6K	﹤0.01%	1284
2016 Q1	–	Sell	-352	Closed	-$3K	–	1493
2015 Q4	$3K	Sell	352 -2,146	-86%	-$18.5K	﹤0.01%	1359
2015 Q3	$21K	Sell	2,498 -92	-4%	-$849	﹤0.01%	1086
2015 Q2	$28K	Sell	2,590 -1,161	-31%	-$14.9K	﹤0.01%	1148
2015 Q1	$52K	Buy	3,751 +112	+3%	+$1.71K	﹤0.01%	1056
2014 Q4	$61K	Buy	+3,639	New	+$53K	﹤0.01%	1065
2014 Q1	–	Sell	-788	Closed	-$11K	–	1476
2013 Q4	$11K	Buy	+788	New	+$11.1K	﹤0.01%	1273
2013 Q3	–	Sell	-9,237	Closed	-$150K	–	1401
2013 Q2	$150K	Buy	+9,237	New	+$286K	﹤0.01%	917

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Japan's INFI Position: Q4 2016 in Review

BlackRock Japan held its Infinity Pharmaceuticals, Inc. (INFI) position steady in Q4 2016 at 7,184 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

BlackRock Japan first reported a position in INFI in Q2 2013 and has held it in 10 quarters since. The position peaked at $150K in Q2 2013. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

BlackRock Japan held 7,184 shares of Infinity Pharmaceuticals, Inc. worth $10K as of Q4 2016.
BlackRock Japan left its Infinity Pharmaceuticals, Inc. share count unchanged in Q4 2016.
Infinity Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1224 holding.
BlackRock Japan first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and has held it in 10 quarters since.
BlackRock Japan's Infinity Pharmaceuticals, Inc. position peaked at $150K in Q2 2013.
94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.